Annual D&A
$189.00M$432.00M-69.57%
Summary
- Current Value
- As of today, MRNA annual D&A is $189.00M, down -69.57% on
- Historical Performance
- MRNA annual D&A is down -18.53% over the past 3 years, and up +509.26% over the past 5 years
- All-Time High Comparison
- MRNA annual D&A is currently -69.57% below its historical high of $621.00M set on
- 3-Year Low Comparison
- MRNA annual D&A is at its 3-year low
- Sector Comparison
- MRNA annual D&A is higher than 91.44% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $189.00M | -69.6% | -18.5% | +509.3% | +7878.1% | |
| Quarterly D&A | $52.00M | 0.0% | -54.0% | +511.8% | +10000.0% | |
| TTM D&A | $208.00M | -37.2% | -39.9% | +539.6% | +10000.0% | |
| Price | $34.30 | -20.6% | -81.3% | -69.6% | – | |
| Annual SG&A | $1.17B | -24.2% | +107.0% | +967.3% | +10000.0% | |
| Annual Total Expenses | $7.18B | -34.7% | +61.7% | +1108.9% | +10000.0% | |
| Annual Operating Expenses | $5.72B | -9.3% | +213.6% | +862.5% | +10000.0% | |
| Annual Revenue | $3.24B | -52.7% | -82.4% | +5274.6% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $621.00M | -69.6% | |
| 5Y | $621.00M | -69.6% | |
| All | $621.00M | -69.6% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $189.00M | at low | |
| 5Y | $31.25M | N/A | +504.8% |
| All | $100.00K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of MRNA?
As of today, MRNA annual D&A is $189.00M
What is 1-year change in MRNA annual D&A?
MRNA annual D&A is down -69.57% year-over-year
What is 3-year change in MRNA annual D&A?
MRNA annual D&A is down -18.53% over the past 3 years
How far is MRNA annual D&A from its all-time high?
MRNA annual D&A is currently -69.57% below its historical high of $621.00M set on December 31, 2023
How does MRNA annual D&A rank versus sector peers?
MRNA annual D&A is higher than 91.44% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly D&A
$52.00M$5.00M-8.77%
Summary
- Current Value
- As of today, MRNA quarterly D&A is $52.00M, down -8.77% on
- Historical Performance
- MRNA quarterly D&A has remained unchanged year-over-year, and down -53.98% over the past 3 years
- All-Time High Comparison
- MRNA quarterly D&A is currently -79.12% below its historical high of $249.00M set on
- 3-Year Low Comparison
- MRNA quarterly D&A is +44.44% above its 3-year low of $36.00M reached on
- Sector Comparison
- MRNA quarterly D&A is higher than 90.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $52.00M | -8.8% | 0.0% | -54.0% | +511.8% | |
| Annual D&A | $189.00M | – | -69.6% | -18.5% | +509.3% | |
| TTM D&A | $208.00M | 0.0% | -37.2% | -39.9% | +539.6% | |
| Price | $34.30 | +24.6% | -20.6% | -81.3% | -69.6% | |
| Quarterly SG&A | $268.00M | +16.5% | -4.6% | -3.6% | +452.1% | |
| Quarterly Total Expenses | $1.22B | +25.8% | -34.2% | -46.5% | +210.6% | |
| Quarterly Operating Expenses | $1.02B | +16.5% | -25.6% | +3.3% | +164.5% | |
| Quarterly Revenue | $1.02B | +615.5% | -45.4% | -69.3% | +543.4% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $60.00M | N/A | -13.3% |
| 3Y | $249.00M | -79.1% | |
| 5Y | $249.00M | -79.1% | |
| All | $249.00M | -79.1% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $39.00M | +33.3% | |
| 3Y | $36.00M | +44.4% | |
| 5Y | $7.71M | N/A | +574.8% |
| All | -$100.00K | >+9999.0% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of MRNA?
As of today, MRNA quarterly D&A is $52.00M
What is MRNA quarterly D&A most recent change?
MRNA quarterly D&A was down -8.77% on September 30, 2025
What is 1-year change in MRNA quarterly D&A?
MRNA quarterly D&A has remained unchanged year-over-year
How far is MRNA quarterly D&A from its all-time high?
MRNA quarterly D&A is currently -79.12% below its historical high of $249.00M set on September 30, 2023
How does MRNA quarterly D&A rank versus sector peers?
MRNA quarterly D&A is higher than 90.64% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM D&A
$208.00M$0.000.00%
Summary
- Current Value
- As of today, MRNA TTM D&A is $208.00M, unchanged on
- Historical Performance
- MRNA TTM D&A is down -37.16% year-over-year, and down -39.88% over the past 3 years
- All-Time High Comparison
- MRNA TTM D&A is currently -66.51% below its historical high of $621.00M set on
- 3-Year Low Comparison
- MRNA TTM D&A is +10.05% above its 3-year low of $189.00M reached on
- Sector Comparison
- MRNA TTM D&A is higher than 91.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $208.00M | 0.0% | -37.2% | -39.9% | +539.6% | |
| Annual D&A | $189.00M | – | -69.6% | -18.5% | +509.3% | |
| Quarterly D&A | $52.00M | -8.8% | 0.0% | -54.0% | +511.8% | |
| Price | $34.30 | +24.6% | -20.6% | -81.3% | -69.6% | |
| TTM SG&A | $35.42B | +3197.7% | +2639.1% | +3597.0% | +10000.0% | |
| TTM Revenue | $2.23B | -27.5% | -56.0% | -89.5% | +804.7% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $208.00M | at high | |
| 3Y | $621.00M | -66.5% | |
| 5Y | $621.00M | -66.5% | |
| All | $621.00M | -66.5% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $189.00M | N/A | +10.1% |
| 3Y | $189.00M | +10.1% | |
| 5Y | $31.25M | N/A | +565.6% |
| All | $0.00 | N/A |
TTM D&A History
FAQ
What is the current TTM D&A of MRNA?
As of today, MRNA TTM D&A is $208.00M
What is MRNA TTM D&A most recent change?
MRNA TTM D&A remained unchanged on September 30, 2025
What is 1-year change in MRNA TTM D&A?
MRNA TTM D&A is down -37.16% year-over-year
How far is MRNA TTM D&A from its all-time high?
MRNA TTM D&A is currently -66.51% below its historical high of $621.00M set on December 31, 2023
How does MRNA TTM D&A rank versus sector peers?
MRNA TTM D&A is higher than 91.23% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna